Recital 10, Regulation (EU) 2020/771

In forcesince 11 Jun 2020

On 19 May 2008, the Commission requested the Authority to evaluate the safety of the five new annatto extracts, at the proposed uses and use levels. Upon analysis of the application, the Authority identified major data gaps and indicated that new toxicological studies would be needed. Consequently, the Commission decided on 14 January 2011 that the safety evaluation of the five new extracts would be carried out as a part of the re-evaluation of Annatto, Bixin, Norbixin (E 160b), as provided for by Regulation (EU) No 257/2010.